IVD Market in China 2017-2021

This industry research report identifies Roche Diagnostics, Abbott, and Siemens Healthineers as the key vendors in the IVD market in China. This industry research report also presents a comprehensive analysis of the market by application (immunochemistry, SMBG, molecular diagnostics, tissue diagnostics, POCT, hematology, clinical microbiology, and hemostasis) and by end-users (hospitals, homecare, research institutes, and independent laboratories).

 In vitro diagnostics market forecast in China

Market research analysts at Technavio predict that the in-vitro diagnostics (IVD) market in China will grow steadily over the next four years and post a CAGR of more than 14% by 2021. This market research analysis identifies an increase in the incidences of chronic and infectious diseases as one of the key growth factors of the IVD market in China. In the recent years, there has been a significant rise in the number of chronic and infectious diseases among children and the millennial population in the country. The prevalence of diagnostic tests such as glucose monitoring, cardiac biomarkers, and cholesterol testing is growing, owing to a rise in the number of illnesses such as diabetes and obesity. Moreover, consumers are moving toward early diagnostic tests to stay precautioned about the illnesses and are thereby taking necessary remedies for the cure. The rising adoption of the early diagnostic tests due to the growing health consciousness among consumers will stimulate the growth of the IVD market in China over the next few years.

To meet the rising demand for healthcare facilities among the consumers, the government of China is primarily focusing on the expansion of healthcare facilities in the rural areas. Moreover, through the stringent government initiatives implemented by the government under the “Healthy China 2020”, the government aims to bridge the gap between the demand and supply of healthcare facilities in all the sections of the society. In addition to the substantial rise in the incidences of chronic and infectious diseases, this expansion of the healthcare infrastructure will also contribute to the growth of the IVD market in China.

Competitive landscape and key vendors

The IVD market in China is characterized by the presence of well-established foreign players. To enhance their market shares, prominent players in the market are focusing on expanding their product portfolio by focusing on innovations. Moreover, the key players are also investing heavily in R&D to retain their foothold in the market.

The leading vendors in the market are –

• Roche Diagnostics
• Abbott
• Siemens Healthineers

The other prominent vendors in the market are Atlas Link Biotech, Autobio Diagnostics, Bioneovan, Bioptik Technology, Bio-Rad Laboratories, Boson Biotech, C&G Biotech, Cepheid, Changchun Wancheng Bio-elect, Changsha City Epower Electronics & Science, Chongqing Haray International Business, Cusabio Biotech, Dako, Fudakang Ind'l, GE Healthcare, Grifols, Maya Medical Equipment Limited, Hologic, Illumina, Innovation Biotech, Intec Products, Jiangxi Zhongchenda Industrial Investment, Jiaxing Smir Medical Devices, Johnson & Johnson, Luminex, Nantong Egens Biotechnology, Nantong Voyage International Trade, PerkinElmer, Qiagen, Quest Diagnostics, Quicking Biotech, Secure Detect, Shanghai Jiuyi International Trade, Shanghai Kehua Bio-Engineering, Shanghai Outdo Biotech, Shenzhen Fitconn Technology, Shiny Health Import & Export, Shenzhen New Industries Biomedical Engineering, Sunrising Enterprise, Wuhan HNC Technology, Yuan Yu Bio-Tech, and Zhejiang Orient Gene Biotech.

IVD market segmentation by application

• Immunochemistry
• SMBG
• Molecular diagnostics
• Tissue diagnostics
• POCT
• Hematology
• Clinical microbiology
• Hemostasis

Based on the IVD market outlook, the immunochemistry segment dominated the IVD market in China. Factors such as the lack of necessitated healthcare infrastructure pave the way for growth opportunities among immunochemistry applications. Also, the application of immunochemistry for the detection of diseases such as hepatitis, illegal drugs, cancer, and fertility problems is further driving the growth of the segment in this market.

Market segmentation by end-user and analysis of the IVD market in China

• Hospitals
• Homecare
• Research institutes
• Independent laboratories

The hospital's segment accounted for the major share of the IVD market in China during 2016. The need for advanced and high-quality diagnostic infrastructure for applications such as diagnosis, analysis, and the treatment for various chronic illness is stimulating the growth of the IVD market in this end-user segment.

Key questions answered in the report include

• What will the IVD market in China size and the growth rate be in 2021?
• What are the key factors driving the IVD market in China?
• What are the key market trends impacting the growth of the IVD market in China?
• What are the challenges to market growth?
• Who are the key vendors in the IVD market in China?
• What are the market opportunities and threats faced by the vendors in the IVD market in China?
• Trending factors influencing the market shares in China?
• What are the key outcomes of the five forces analysis of the IVD market in China?

Technavio also offers customization on reports based on specific client requirement